HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activity of the Keggin polyoxotungstate PM-19 against herpes simplex virus type 2 infection in immunosuppressed mice: role of peritoneal macrophage activation.

Abstract
The in vivo antiviral activity of the Keggin polyoxotungstate PM-19 [K7(PTi2W10O40).6H2O] against herpes simplex virus type 2 (HSV-2) was investigated in mice immunosuppressed by cyclophosphamide (CY). When PM-19 was administered intraperitoneally to immunosuppressed mice for 3 days (once daily) starting at the time of infection, it prevented death due to HSV-2 encephalitis in a dose-dependent manner (10-25 mg/kg). The in vivo anti-HSV-2 activity of PM-19 was superior to that of acyclovir. Intraperitoneal administration of PM-19 to the immunosuppressed mice significantly increased the number of peritoneal cells, especially macrophages. PM-19 did not stimulate interferon-inducing activity or natural killer cell activity, but markedly enhanced peritoneal macrophage functions: (1) phagocytic activity as assessed by measuring the amount of 51Cr-labeled sheep red blood cells taken into the macrophages, and (2) extrinsic antiviral activity as monitored by reduction in the numbers of plaque formed upon cocultivation of HSV-2-infected HEL cells with the macrophages. These results point to the role of peritoneal macrophage activation in the activity of PM-19 against HSV-2 infection in immunosuppressed mice.
AuthorsS Ikeda, S Nishiya, A Yamamoto, T Yamase, C Nishimura, E De Clercq
JournalJournal of medical virology (J Med Virol) Vol. 41 Issue 3 Pg. 191-5 (Nov 1993) ISSN: 0146-6615 [Print] United States
PMID8263499 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Polymers
  • Tungsten Compounds
  • polyoxotungstate PM 19
  • Acyclovir
Topics
  • Acyclovir (therapeutic use)
  • Animals
  • Antiviral Agents (therapeutic use)
  • Cell Line
  • Female
  • Herpes Simplex (drug therapy, immunology)
  • Herpesvirus 2, Human (drug effects)
  • Humans
  • Immunocompromised Host
  • Killer Cells, Natural (drug effects, immunology)
  • Lung
  • Lymphocyte Activation (drug effects)
  • Macrophage Activation (drug effects)
  • Macrophages, Peritoneal (drug effects, immunology)
  • Mice
  • Phagocytosis (drug effects)
  • Polymers (therapeutic use)
  • Radioimmunoassay
  • Tungsten Compounds (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: